Update on information about the Corona pandemic for patients with allergic diseases

Allergopharma GmbH & Co. KG would like to inform you about the latest recommendations from German specialist societies… Read more

Update on the Corona pandemic for patients with allergic diseases

Considering the current highly dynamic situation, Allergopharma GmbH & Co. KG would like to provide you with the latest… Read more

Merck Successfully Divests Allergopharma

Darmstadt, Germany, March 31, 2020 – Merck, a leading science and technology company, today completed the divestment of… Read more

Responsible Action during the Coronvirus Crisis

Since the coronavirus crisis began, the Allergopharma GmbH & Co. KG took consequent measures at its sites in Germany,… Read more

Merck divests Allergopharma to Dermapharm

Today, Merck and the Dermapharm Holding SE have signed an agreement for the acquisition of all shares of Allergopharma. … Read more

19th EAACI Allergopharma Research Award presented

Dr. Flore Amat accepts prize for her research in allergology Reinbek, Germany June 27, 2019 – Allergopharma, the… Read more

FASIT-Workshop brings together experts in allergology

Allergopharma traditionally invites leading experts in the field of allergen specific immunotherapy (AIT) every… Read more

Allergopharma donates DGAKI award at 13th German Allergy Congress

Allergopharma supports young researchers with a 5,000 Euro “Allergene Immunotherapy” award by the German Society for… Read more

“Stifterverband fuer die deutsche Wissenschaft e.V.” honours Allergopharma's research activities

Allergopharma receives the “Innovative through Research” seal of approval for the second time Reinbek… Read more

Allergopharma presents its New Corporate Branding at the EAACI Congress 2018 in Munich

Reinbek - Allergopharma, the allergy business of Merck, is presenting its new brand identity. For 50 years, the allergy… Read more

Allergopharma Opens new Biopharmaceutical Production in Reinbek

Reinbek – Merck, a leading science and technology company, announced today, that its allergy business Allergopharma… Read more

Allergopharma invests € 40 million in production facility

The German pharmaceutical, chemical and life science company Merck broke ground today on a new production facility for… Read more